Literature DB >> 1963291

Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis.

R C Goldman1, J O Capobianco.   

Abstract

We have elucidated a new mechanism for bacterial resistance to the 14-membered macrolides oleandomycin and erythromycin and the 15-membered macrolide azithromycin. Plasmid pNE24, previously isolated from a clinical specimen of Staphylococcus epidermidis, was characterized as causing resistance to 14-membered but not 16-membered macrolides by a mechanism suggested to involve reduced antibiotic permeation of bacterial cells (B. C. Lampson, W. von David, and J. T. Parisi, Antimicrob. Agents Chemother. 30:653-658, 1986). Our recent investigations have demonstrated that S. epidermidis 958-2 containing plasmid pNE24 also contains an energy-dependent macrolide efflux pump which maintains intracellular antibiotic concentrations below those required for binding to ribosomes. Thus, when strain 958-2 was pretreated with the inhibitor carbonyl cyanide m-chlorophenylhydrazone (CCCP), macrolide accumulated at the same rate and to the same extent as in CCCP-treated or untreated control cells lacking plasmid pNE24 (strain 958-1). In contrast, macrolide did not accumulate in energy-competent strain 958-2 but did accumulate to levels equal to those of ribosomes immediately following CCCP addition. Furthermore, intracellular macrolide was excreted and bacteria resumed growth when CCCP but not macrolide was removed from the growth medium. As expected, the 16-membered macrolide niddamycin accumulated to the same level in energy-competent strains 958-1 and 958-2 at the same rapid rate. Macrolide incubated with lysates prepared from both strains or recovered from cells of strain 958-2 was unmodified and bound to ribosomes from strains 958-1 and 958-2 with identical affinities and kinetics, thus precluding a role for ribosome or drug alteration in the resistance mechanism. We conclude that the presence of plasmid pNE24 results in specific energy-dependent efflux of 14- and 15-membered macrolides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963291      PMCID: PMC171974          DOI: 10.1128/AAC.34.10.1973

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Selective action of erythromycin on initiating ribosomes.

Authors:  P C Tai; B J Wallace; B D Davis
Journal:  Biochemistry       Date:  1974-10-22       Impact factor: 3.162

2.  Studies on the antibiotics from Streptomyces spinichromogenes var. kujimyceticus. V. Some antimicrobial characteristics of kujimycin A and kujimycin B against macrolide resistant staphylococci.

Authors:  S Omura; S Namiki; M Shibata; T Muro; J Sawada
Journal:  J Antibiot (Tokyo)       Date:  1970-09       Impact factor: 2.649

3.  Acid degradation of erythromycin A and erythromycin B.

Authors:  P Kurath; P H Jones; R S Egan; T J Perun
Journal:  Experientia       Date:  1971-04-15

Review 4.  Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics.

Authors:  D Dubnau
Journal:  CRC Crit Rev Biochem       Date:  1984

5.  Monocarboxylic acid permeation through lipid bilayer membranes.

Authors:  A Walter; J Gutknecht
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

6.  Binding of [14C]erythromycin to Escherichia coli ribosomes.

Authors:  S Pestka
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

7.  Accumulation in gram-postive and gram-negative bacteria as a mechanism of resistance to erythromycin.

Authors:  J C Mao; M Putterman
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

8.  Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics.

Authors:  R Skinner; E Cundliffe; F J Schmidt
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

9.  Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus.

Authors:  C J Lai; B Weisblum
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance.

Authors:  P Barthélémy; D Autissier; G Gerbaud; P Courvalin
Journal:  J Antibiot (Tokyo)       Date:  1984-12       Impact factor: 2.649

View more
  10 in total

Review 1.  Active efflux mechanisms for antimicrobial resistance.

Authors:  S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

2.  Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin.

Authors:  J A Retsema; A E Girard; L A Brennan; C R Cimochowski; J A Faiella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

Review 3.  Review of macrolides and ketolides: focus on respiratory tract infections.

Authors:  G G Zhanel; M Dueck; D J Hoban; L M Vercaigne; J M Embil; A S Gin; J A Karlowsky
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

5.  Modeling the Kinetics of the Permeation of Antibacterial Agents into Growing Bacteria and Its Interplay with Efflux.

Authors:  Wright W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

6.  Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

Authors:  C J Beckers; D S Roos; R G Donald; B J Luft; J C Schwab; Y Cao; K A Joiner
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

7.  Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells.

Authors:  W S Champney; C L Tober
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 8.  Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D H Peters; H A Friedel; D McTavish
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

9.  Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  W Yan; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

10.  Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 System: comparison with results obtained with the Vitek-2 and Phoenix systems.

Authors:  Patrick Tang; Donald E Low; Sandra Atkinson; Karen Pike; Aisha Ashi-Sulaiman; Andrew Simor; Susan Richardson; Barbara M Willey
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.